Searched for
CYMBALTA
Dr Reddy's Lab launches duloxetine delayed-release capsulesCymbalata (duloxetine delayed- release capsules) brand and generic had US sales of $5.04 billion for the most recent 12 months ending April...27 Jun, 2014, 12.41 PM IST- Brokerages raise Torrent Pharma target price post Q4 resultsThe company reported 120 per cent surge in consolidated net profit to Rs 244 crore against a net profit of Rs 111 crore in the correspondin...12 May, 2014, 11.30 AM IST
- Lupin: US launches, better movement of rupee add valueDrugmaker Lupin’s performance in the quarter to December indicates a better showing by the company in the second half of the current fiscal.04 Feb, 2014, 10.37 AM IST
- Lupin acquires Netherlands-based Nanomi BV, focus on injectiblesNanomi has a rich talent pool of scientists who would be backed by Lupin's global R&D and manufacturing teams, the Mumbai-based firm said.04 Feb, 2014, 02.30 AM IST
- Lupin rallies 4.5% in a weak market post Q3 results; top Nifty gainerLupin rallied as much as 4.8% in trade on Monday in a weak market, after the drugmaker reported a 42% growth in its quarterly net profit.03 Feb, 2014, 04.40 PM IST
- Lupin's earnings outperform Street expectations, to stay our top pick: Kirit Gogri, Quant Broking"The US business has been a big game changer for Lupin and I am presuming that the US business would have delivered much superior numbers t...03 Feb, 2014, 03.15 PM IST
- Torrent Pharma Q3 PAT seen up 16% at Rs 130 croreThe company’s net sales in Dec 2013 quarter are seen at Rs 950 crore, up 23 per cent, as compared to Rs 769 crore in the year-ago period.20 Jan, 2014, 06.11 PM IST
- Dr. Reddy’s & Sun Pharma to see strong Q3 earnings growth: Arvind Bothra, Religare"Lupin would have a stable revenue growth merely because some of the recent launches that they have had have been in the latter part of the...06 Jan, 2014, 04.22 PM IST
- Wockhardt dogged by regulatory issues, prefer Aurobindo Pharma instead: Ranjit Kapadia"Wockhardt has been languishing for some time now, whereas in case of Aurobindo, there is a steady flow of news on the launch of their gene...20 Dec, 2013, 02.56 PM IST
- Sun Pharma gets USFDA nod for anti-depressant drugThe company said its subsidiary has received nod from the US Food and Drug Administration to market Duloxetine Delayed-Release Capsules.12 Dec, 2013, 05.16 PM IST
- Several Indian companies get FDA nod for anti-depressant drugThe US Food and Drug Administration has approved the first generic versions of Cymbalta, a prescription medicine used in treatment of depre...12 Dec, 2013, 04.00 PM IST
- Brokerages up target price on Lupin to over Rs 1,000 post Q2 resultsAs many as seven brokerage firms have a target price of over Rs 1,000, which translates into gains of over 10 per cent in the next one year.31 Oct, 2013, 10.47 AM IST
- Wockhardt gets USFDA tentative nod to sell anti-depressantDrug firm Wockhardt said it has received tentative approval from USFDA to market generic Duloxetine Hydrochloride capsules, used for treati...08 Jul, 2011, 01.13 PM IST
- Wockhardt get tentative nod from USFDA for Duloxetine, stk upWockhardt has received tentative approval from the USFDA for Duloxetine, a generic version of depression drug Cymbalta.08 Jul, 2011, 12.22 PM IST
- Lilly 1Q profit rises on higher sales, flat costsDrugmaker Eli Lilly & Co. said Monday its first-quarter profit rose 24 per cent on a boost in sales of the antidepressant Cymbalta and the ...20 Apr, 2009, 05.32 PM IST
- Drug firms fight with foreign cos over patentsPharma companies are at loggerheads with their foreign counterparts over patent rights. Global pharma giants have been filing cases against...04 Dec, 2008, 01.44 AM IST
- Eli Lilly Q3 net rises 10% $874mEli Lilly said on Thursday that its profit rose 10% during the third quarter on modest growth by its best-selling drug, the antipsychotic Z...21 Oct, 2006, 12.44 AM IST
Load More
